|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Net income (loss) | |||||
| Adjustments to reconcile net loss to net cash used in operating activities: | |||||
| Software amortization | |||||
| Depreciation | |||||
| Common stock issued for services | |||||
| Series B stock issued for services | |||||
| Accounts receivable allowance | |||||
| Subscription receivable | |||||
| Fixed assets, net | |||||
| Acquired intangible assets | |||||
| Change in assets and liabilities: | |||||
| Gross accounts receivable | |||||
| Prepaid | |||||
| OID Promissory Note | |||||
| Loan receivable | |||||
| Related party receivable | |||||
| Accounts payable | |||||
| Other current liabilities | |||||
| Accrued interest | |||||
| Customer funds | |||||
| Fair value of trading position, net | |||||
| Operating lease | |||||
| Deferred taxes | |||||
| Related party guarantee | |||||
| Trade and tax receivable | |||||
| Accrued income | |||||
| Right of use of assets (lease) | |||||
| Accrued expenses, related party | |||||
| Net cash used in operating activities | |||||
| Investing Activities: | |||||
| Capitalized software | |||||
| Effect of exchange rates | |||||
| Business acquisition seller’s note | |||||
| Changes in paid-in capital | |||||
| Purchase price of acquisitions | |||||
| Net cash used in investing activities | |||||
| Financing Activities: | |||||
| Borrowing from (payments to) line of credit | |||||
| Promissory Note | |||||
| Net proceeds from CARES Act - paycheck protection program | |||||
| Net proceeds from SBA loan | |||||
| Related party advances | |||||
| Stock issued for financing | |||||
| Common stock issued for cash | |||||
| Series A for cash | |||||
| Common stock issued at a discount | |||||
| Series A for cash and cancelation | |||||
| Capital contribution | |||||
| Noncontrolling interest | |||||
| Net cash provided by financing activities | |||||
| Net increase in cash | |||||
| Cash at beginning of the period | |||||
| Cash at end of the period | |||||
| Common stock issued for financing & warrant settlement | |||||
| Series B Preferred Stock for acquisition | |||||
Loading...